December 27, 2013
MSD K.K. announced on December 24 that it filed on the same day a new drug application (NDA) for its chronic hepatitis C treatment vaniprevir with the Ministry of Health, Labor and Welfare (MHLW). Vaniprevir is an antiviral agent, which...read more